Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy.

Tina VilsbøllStephen C BainLawrence Alan Leiter Ildiko LingvayDavid MatthewsRafael SimóIda Carøe HelmarkNelun WijayasingheMichael Larsen

Published in: Diabetes, obesity & metabolism (2018)

Early worsening of DR is a known phenomenon associated with the rapidity and magnitude of improvement in glycaemic control with insulin; the DRC findings in SUSTAIN 6 are consistent with this. Guidance regarding the early worsening of DR is recommended with insulin. Similar recommendations may be appropriate for semaglutide.

Keyphrases

diabetic retinopathy
type diabetes
optical coherence tomography
editorial comment
clinical practice
metabolic syndrome
adipose tissue